# Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis

**Authors:** Pooya Jalali, Malihe Rezaee, Alireza Yaghoobi, Moein Piroozkhah, Mohammad Reza Zabihi, Shahram Aliyari, Zahra Salehi

PMC · DOI: 10.1186/s44342-025-00045-4 · Genomics & Informatics · 2025-05-15

## TL;DR

This study identifies shared molecular pathways between ulcerative colitis and primary sclerosing cholangitis, offering new insights into their connection and potential treatment targets.

## Contribution

The study reveals novel candidate genes and molecular networks linking ulcerative colitis and primary sclerosing cholangitis.

## Key findings

- 132 SNPs and 56 differentially expressed genes were found to be shared between UC and PSC.
- PTPN2 is the only gene common at both SNP and expression levels in UC and PSC.
- A ceRNA network involving 4 mRNAs, 94 miRNAs, and 200 circRNAs was identified.

## Abstract

Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders, including ulcerative colitis (UC) and Crohn’s disease, affecting the gastrointestinal tract and is associated with high morbidity and mortality. Accumulating evidence indicates that IBD not only impacts the gastrointestinal tract but also affects multiple extraintestinal organs, which may manifest prior to the diagnosis of IBD. Among these extraintestinal manifestations associated with IBD, primary sclerosing cholangitis (PSC) stands out as a prominent example. PSC is recognized as a progressive cholestatic disorder, characterized by the narrowing of bile ducts, eventual development of liver cirrhosis, end-stage liver disease, and the potential emergence of cholangiocarcinoma. This study aimed to identify the molecular contributors in UC-induced PSC by detecting the essential regulatory genes that are differentially expressed in both diseases.

The common single-nucleotide polymorphisms (SNPs) and differentially expressed genes (DEGs) were detected using DisGeNET and GEO databases, respectively. Then, the top module and hub genes within the protein–protein interaction network were identified. Furthermore, the co-expression network of the top module was constructed using the HIPPIE database. Additionally, the gene regulatory network was constructed based on miRNAs and circRNAs. Finally, we searched the DGIdb database for possible interacting drugs with UC-PSC top module genes.

A total of 132 SNPs and their associated genes were found to be shared between UC and PSC. Gene expression analysis identified 56 common DEGs between the two diseases. Following functional enrichment analysis, 207 significant biological processes (BP), 48 molecular functions (MF), and 8 KEGG pathways, with notable enrichment in mRNA-related processes such as mRNA splicing and RNA binding, were defined. Particularly, the PTPN2 gene was the only gene common between UC and PSC at both the SNP level and the expression level. Additionally, the top cluster of PPI network analysis was consisted of PABPC1, SNRPA1, NOP56, NHP2L1, and HNRNPA2B1 genes. Finally, ceRNA network involving 4 mRNAs, 94 miRNAs, and 200 selected circRNAs was constructed.

The present study provides novel potential candidate genes that may be involved in the molecular association between ulcerative colitis and primary sclerosing cholangitis, resulting in the development of diagnostic tools and therapeutic targets to prevent the progression of PSC from UC.

The online version contains supplementary material available at 10.1186/s44342-025-00045-4.

## Linked entities

- **Genes:** PTPN2 (protein tyrosine phosphatase non-receptor type 2) [NCBI Gene 5771], PABPC1 (poly(A) binding protein cytoplasmic 1) [NCBI Gene 26986], SNRPA1 (small nuclear ribonucleoprotein polypeptide A') [NCBI Gene 6627], NOP56 (NOP56 ribonucleoprotein) [NCBI Gene 10528], SNU13 (small nuclear ribonucleoprotein 13) [NCBI Gene 4809], HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1) [NCBI Gene 3181]
- **Diseases:** ulcerative colitis (MONDO:0005101), primary sclerosing cholangitis (MONDO:0013433), Inflammatory bowel disease (MONDO:0005265), Crohn’s disease (MONDO:0005011), end-stage liver disease (MONDO:0100193), cholangiocarcinoma (MONDO:0019087)

## Full-text entities

- **Genes:** IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, SNRPA1 (small nuclear ribonucleoprotein polypeptide A') [NCBI Gene 6627] {aka Lea1, U2A'}, MIR6133 (microRNA 6133) [NCBI Gene 102465139] {aka hsa-mir-6133}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, MIR6129 (microRNA 6129) [NCBI Gene 102465137] {aka hsa-mir-6129}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, PSC (Cholangitis, primary sclerosing) [NCBI Gene 100653366], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, PABPC1 (poly(A) binding protein cytoplasmic 1) [NCBI Gene 26986] {aka PAB1, PABP, PABP1, PABPC2, PABPL1}, NOP56 (NOP56 ribonucleoprotein) [NCBI Gene 10528] {aka NOL5A, SCA36}, MIR4784 (microRNA 4784) [NCBI Gene 100616378], MIR1225 (microRNA 1225) [NCBI Gene 100188847] {aka MIRN1225}, BANF1 (barrier to autointegration nuclear assembly factor 1) [NCBI Gene 8815] {aka BAF, BCRP1, D14S1460, NGPS}, KCNK18 (potassium two pore domain channel subfamily K member 18) [NCBI Gene 338567] {aka K2p18.1, MGR13, TRESK, TRESK-2, TRESK2, TRIK}, PTPRU (protein tyrosine phosphatase receptor type U) [NCBI Gene 10076] {aka FMI, PCP-2, PTP, PTP-J, PTP-PI, PTP-RO}, MIR4465 (microRNA 4465) [NCBI Gene 100616180], CEP63 (centrosomal protein 63) [NCBI Gene 80254] {aka SCKL6}, MIR4510 (microRNA 4510) [NCBI Gene 100616293] {aka mir-4510}, CFH (complement factor H) [NCBI Gene 3075] {aka AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH}, CD6 (CD6 molecule) [NCBI Gene 923] {aka TP120}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, MIR3183 (microRNA 3183) [NCBI Gene 100422835] {aka mir-3183}, MIR6785 (microRNA 6785) [NCBI Gene 102466911] {aka hsa-mir-6785}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PTPN2 (protein tyrosine phosphatase non-receptor type 2) [NCBI Gene 5771] {aka PTN2, PTPT, TC-PTP, TC45, TC48, TCELLPTP}, U2AF2 (U2 small nuclear RNA auxiliary factor 2) [NCBI Gene 11338] {aka DEVDFB, U2AF65}, MIR6127 (microRNA 6127) [NCBI Gene 102466615] {aka hsa-mir-6127}, IL23R (interleukin 23 receptor) [NCBI Gene 149233] {aka PSORS7}, HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1) [NCBI Gene 3181] {aka HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2}, CUL3 (cullin 3) [NCBI Gene 8452] {aka CUL-3, NEDAUS, PHA2E}, TLR9 (toll like receptor 9) [NCBI Gene 54106] {aka CD289}, IL18R1 (interleukin 18 receptor 1) [NCBI Gene 8809] {aka CD218a, CDw218a, IL-18R, IL-18R-alpha, IL-18Ralpha, IL-1Rrp}, MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, SCN5A (sodium voltage-gated channel alpha subunit 5) [NCBI Gene 6331] {aka CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD}, DHX15 (DEAH-box helicase 15) [NCBI Gene 1665] {aka DBP1, DDX15, PRP43, PRPF43, PrPp43p, hPrp43}, MIR4444-1 (microRNA 4444-1) [NCBI Gene 100616394] {aka MIR4444, hsa-mir-4444-1, miR-4444-1}, IFNG-AS1 (IFNG regulatory antisense RNA 1) [NCBI Gene 100885789] {aka GS1-410F4.2, NEST, Tmevpg1}, YTHDC1 (YTH N6-methyladenosine RNA binding protein C1) [NCBI Gene 91746] {aka YT521, YT521-B}, SNU13 (small nuclear ribonucleoprotein 13) [NCBI Gene 4809] {aka 15.5K, FA-1, FA1, NHP2L1, NHPX, OTK27}, IL19 (interleukin 19) [NCBI Gene 29949] {aka IL-10C, MDA1, NG.1, ZMDA1}
- **Diseases:** strictures of bile ducts (MESH:D001649), IBD (MESH:D015212), UC (MESH:D003093), cholestatic disease (MESH:D002779), migraine (MESH:D008881), cancer (MESH:D009369), autoimmune (MESH:D001327), ductal obstruction (MESH:D044584), colorectal cancer (MESH:D015179), EIMs (MESH:D012877), fibrosis (MESH:D005355), Inflammation (MESH:D007249), liver cirrhosis (MESH:D008103), genetic disorders (MESH:D030342), idiopathic (MESH:D002311), chronic (MESH:D002908), intestinal dysbiosis (MESH:D064806), end-stage liver disease (MESH:D058625), cholangiocarcinoma (MESH:D018281), CD (MESH:D003424), Ulcerative cholangitis (MESH:D002761), MF (MESH:C567116), PSC (MESH:D015209), celiac disease (MESH:D002446)
- **Chemicals:** N6-methyladenosine (MESH:C010223), m6 A (MESH:C005955), H2S (MESH:D006862), sulfur (MESH:D013455), cloxyquin (MESH:C519493), dipicolinic acid (MESH:C004860), CHEMBL585964 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs12968719, rs11614178, rs2104286, rs183686347, rs12075255, rs1893217, rs2847297, rs1883832, rs62097857, rs10889676, rs12987977, rs11230563
- **Cell lines:** HEK- 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), COS- 7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12082998/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12082998/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12082998/full.md

---
Source: https://tomesphere.com/paper/PMC12082998